SCHEMBL5202260

SCHEMBL5202260

Cc1c(NS(C)(=O)=O)cccc1OCC1=NCCN1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 10/20 0.66
NISCH Q9Y2I1 10/20 0.56
HTR1A P08908 4/20 0.50
ADRA2A P08913 4/20 0.50
ADRA2B P18089 4/20 0.50
ADRA2C P18825 4/20 0.50
ADRA1D P25100 4/20 0.48
ADRA1B P35368 4/20 0.48
MAOA P21397 1/20 0.48
MAOB P27338 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
THRB P10828 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
THPO P40225 1/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5201322 0.99 ADRA1A (0.65) ADRA1ANISCHHTR1AADRA2AADRA2B
Hydrochloric Acid SCHEMBL5200769 0.86 ADRA1A (0.55) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5201551 0.82 ADRA1A (0.64) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5201030 0.81 ADRA1A (0.80) ADRA1ANISCHHTR1AADRA2AADRA2B
Hydrochloric Acid SCHEMBL5203301 0.81 ADRA1A (0.62) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5201781 0.80 ADRA1A (0.58) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5200657 0.80 TAAR1 (0.52) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5204186 0.80 ADRA1A (0.67) ADRA1ANISCHHTR1AADRA2AADRA2B
Dabuzalgron SCHEMBL5203336 0.80 ADRA1A (1.00) ADRA1ANISCHHTR1AADRA2AADRA2B
SCHEMBL5200474 0.80 ADRA1A (0.77) ADRA1ANISCHHTR1AADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed